CPG
BNTX icon

Cornerstone Planning Group’s BioNTech BNTX Stock Holding History

Cornerstone Planning Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$115 – 1548
2025
Q1 		$115 Hold
1
– – ﹤0.01% 1495
2024
Q4 		$120 Buy
+1
New +$114 ﹤0.01% 1347

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cornerstone Planning Group's BNTX Position: Q2 2025 in Review

Cornerstone Planning Group sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 1 share — an estimated $115 sold.

Cornerstone Planning Group first reported a position in BNTX in Q4 2024 and held it in 2 quarters. The position peaked at $120 in Q4 2024. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Cornerstone Planning Group reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Cornerstone Planning Group sold 1 BioNTech share in Q2 2025, an estimated $115.
  • Cornerstone Planning Group first reported a position in BioNTech in Q4 2024 and held it in 2 quarters.
  • Cornerstone Planning Group's BioNTech position peaked at $120 in Q4 2024.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Cornerstone Planning Group's 13F filing for Q2 2025, filed 11 Aug 2025.